For pharmaceutical companies rebutting price fixing claims, members of The Brattle Group performed a comprehensive analysis of industry profitability. This analysis included critiquing claims regarding pharmaceutical development costs, risks, and returns. A complex drug research simulation model was also developed, refined, and completed.